MAKERS LABORATORIES LTD. Share Price
MAKERS LABORATORIES LTD. Share Price Today
As of 25 Jul 2026, MAKERS LABORATORIES LTD. share price is ₹148.40. The stock opened at ₹148.00, compared to its previous close of ₹148.00. During today's trading session, MAKERS LABORATORIES LTD. share price moved in the range of ₹148.00 to ₹151.25, with an average price of ₹149.63 for the day. Looking at its last 52-week, the stock has touched a low of ₹109.00 and a high of ₹186.70.
MAKERS LABORATORIES LTD. Returns Calculator
MAKERS LABORATORIES LTD. Shareholder Returns
MAKERS LABORATORIES LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,65,711.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,93,860.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,92,687.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,12,593.00 | 33.55 | 3.27 | 11.27% | 0.00 | 14.95% | 423.36 | 0.93% | 0.44 | 43.52 |
| Zydus Lifesciences | 1,11,082.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,09,553.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,05,607.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 96,204.70 | 30.22 | 2.53 | 11.07% | 0.18 | 12.54% | 377.96 | 0.69% | 0.41 | 38.68 |
| Aurobindo Pharma | 88,508.40 | 25.27 | 2.34 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 84,727.30 | 60.26 | 10.10 | 18.21% | 0.40 | 16.70% | 97.21 | 0.12% | 0.64 | 13.72 |
MAKERS LABORATORIES LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹140.59 | ₹120.75 | ₹104.39 | ₹101.28 |
| Other Income | ₹1.71 | ₹11.89 | ₹1.53 | ₹2.28 |
| Total Revenue | ₹142.30 | ₹132.64 | ₹105.92 | ₹103.55 |
| Total Expenses | ₹131.16 | ₹118.44 | ₹109.83 | ₹104.39 |
| Profit Before Tax | ₹11.15 | ₹13.41 | -₹3.92 | -₹0.84 |
| Tax | ₹3.29 | ₹2.50 | ₹0.89 | ₹1.35 |
| Profit After Tax | ₹7.86 | ₹10.91 | -₹4.81 | -₹2.19 |
| EPS - Basic | ₹3.99 | ₹12.70 | -₹10.62 | -₹7.90 |
| EPS - Diluted | ₹3.99 | ₹12.70 | -₹10.62 | -₹7.90 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹11.15 | ₹13.41 | -₹3.92 | -₹0.84 |
| Income before WC changes | ₹15.98 | ₹9.52 | ₹1.87 | ₹4.81 |
| Change in Assets | -₹7.20 | -₹3.30 | -₹6.13 | -₹14.93 |
| Change in Liabilities | ₹8.82 | -₹7.90 | ₹6.87 | ₹3.97 |
| Change in WC | ₹1.62 | -₹11.20 | ₹0.74 | -₹10.96 |
| Cash flow from Operations | ₹14.29 | -₹4.08 | ₹0.84 | -₹8.62 |
| Cash flow from Investing | -₹14.69 | ₹19.75 | -₹6.89 | ₹1.25 |
| Cash flow from Financing | ₹0.35 | -₹15.84 | ₹5.74 | ₹5.78 |
| Total Cash Flow | -₹0.05 | -₹0.17 | -₹0.31 | -₹1.59 |
| Cash (Start of the year) | ₹0.24 | ₹0.41 | ₹0.72 | ₹2.31 |
| Cash (End of the year) | ₹0.20 | ₹0.24 | ₹0.41 | ₹0.72 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹79.67 | ₹79.68 | ₹91.45 | ₹89.04 |
| Current Assets | ₹86.95 | ₹68.27 | ₹69.80 | ₹63.25 |
| Total Assets | ₹166.62 | ₹147.95 | ₹161.26 | ₹152.30 |
| Current Liabilities | ₹34.02 | ₹21.20 | ₹37.17 | ₹27.54 |
| Net Current Asset | ₹52.93 | ₹47.07 | ₹32.63 | ₹35.71 |
| Non-Current Liabilities | ₹10.12 | ₹11.56 | ₹19.75 | ₹15.08 |
| Equity Capital | ₹122.48 | ₹115.19 | ₹104.34 | ₹109.67 |
| Total Equity & Liabilities | ₹166.62 | ₹147.95 | ₹161.26 | ₹152.30 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹50.35 | ₹42.94 | ₹49.09 | ₹42.55 |
| Other Income | ₹0.59 | ₹10.92 | ₹1.15 | ₹1.14 |
| Total Revenue | ₹50.94 | ₹53.87 | ₹50.24 | ₹43.68 |
| Total Expenses | ₹52.95 | ₹48.94 | ₹57.20 | ₹50.46 |
| Profit Before Tax | -₹2.01 | ₹4.93 | -₹6.96 | -₹6.78 |
| Tax | -₹0.29 | ₹0.29 | -₹0.01 | -₹0.41 |
| Profit After Tax | -₹1.72 | ₹4.64 | -₹6.95 | -₹6.36 |
| EPS - Basic | -₹2.91 | ₹7.87 | -₹11.78 | -₹10.58 |
| EPS - Diluted | -₹2.91 | ₹7.87 | -₹11.78 | -₹10.58 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | -₹2.01 | ₹4.93 | -₹6.96 | -₹6.78 |
| Income before WC changes | ₹0.80 | -₹1.80 | -₹3.32 | -₹3.45 |
| Change in Assets | -₹4.13 | ₹4.52 | -₹1.93 | ₹1.88 |
| Change in Liabilities | ₹1.90 | -₹3.87 | ₹2.51 | ₹0.54 |
| Change in WC | -₹2.22 | ₹0.65 | ₹0.57 | ₹2.42 |
| Cash flow from Operations | -₹2.02 | -₹1.59 | -₹3.06 | -₹1.42 |
| Cash flow from Investing | ₹0.28 | ₹16.14 | -₹2.04 | -₹3.55 |
| Cash flow from Financing | ₹1.75 | -₹14.56 | ₹5.12 | ₹4.94 |
| Total Cash Flow | ₹0.00 | -₹0.01 | ₹0.02 | -₹0.04 |
| Cash (Start of the year) | ₹0.02 | ₹0.03 | ₹0.01 | ₹0.05 |
| Cash (End of the year) | ₹0.02 | ₹0.02 | ₹0.03 | ₹0.01 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹53.50 | ₹55.34 | ₹65.30 | ₹65.63 |
| Current Assets | ₹20.03 | ₹16.06 | ₹20.85 | ₹19.16 |
| Total Assets | ₹73.54 | ₹71.40 | ₹86.15 | ₹84.79 |
| Current Liabilities | ₹17.76 | ₹13.47 | ₹25.73 | ₹20.91 |
| Net Current Asset | ₹2.27 | ₹2.59 | -₹4.89 | -₹1.75 |
| Non-Current Liabilities | ₹1.34 | ₹1.85 | ₹8.96 | ₹5.59 |
| Equity Capital | ₹54.43 | ₹56.08 | ₹51.45 | ₹58.28 |
| Total Equity & Liabilities | ₹73.54 | ₹71.40 | ₹86.15 | ₹84.79 |
About MAKERS LABORATORIES LTD.
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
MAKERS LABORATORIES LTD. Financial Highlights
- Revenue: MAKERS LABORATORIES LTD. reported revenue of ₹142.30 crore in FY26 vs ₹132.64 crore in FY25. It showed an increase of 7.28% on a yearly basis.
- Operating Profit: MAKERS LABORATORIES LTD. reported an operating profit of ₹11.15 crore in FY26 vs ₹13.41 crore in FY25. It showed a decrease of 16.85% on a year-on-year basis.
- Net Profit: MAKERS LABORATORIES LTD. reported a net profit of ₹7.86 crore in FY26 vs ₹10.91 crore in FY25. It showed a decrease of 27.96% on a yearly basis.
MAKERS LABORATORIES LTD. Quarterly Result Highlights
- MAKERS LABORATORIES LTD. reported revenue of ₹36.51 crore in Mar 2026, compared with ₹36.00 crore in Dec 2025, representing an increase of 1.42% on a quarter-on-quarter (QoQ) basis.
- MAKERS LABORATORIES LTD. reported an operating profit of ₹4.73 crore in Mar 2026, compared with ₹3.15 crore in Dec 2025, representing an increase of 50.16% on a quarter-on-quarter (QoQ) basis.
- MAKERS LABORATORIES LTD. reported a profit of ₹3.56 crore in Mar 2026, compared with ₹2.27 crore in Dec 2025, reflecting an increase of 56.83% on a QoQ basis.
- The earnings per share (EPS) of MAKERS LABORATORIES LTD. stood at ₹3.99 during Mar 2026.
Similar Stocks
FAQs on MAKERS LABORATORIES LTD. Share Price
What is MAKERS LABORATORIES LTD. share price today?
MAKERS LABORATORIES LTD. share price is ₹148.40 as on 24 Jul, 2026, 15:22 IST.
How has the MAKERS LABORATORIES LTD. share price performed in the past?
In the last 1 year, MAKERS LABORATORIES LTD. delivered a return of -2.79%. The MAKERS LABORATORIES LTD. share price hit a high of ₹186.70 and low of ₹109.00.
How much is the Mutual Fund shareholding in MAKERS LABORATORIES LTD. shares?
The Mutual Fund Shareholding in MAKERS LABORATORIES LTD. was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of MAKERS LABORATORIES LTD. shares ?
The 52-week high and low of MAKERS LABORATORIES LTD. share is ₹186.70 and ₹109.00 as of 24 Jul, 2026.
What is the market cap of MAKERS LABORATORIES LTD.?
The market capitalisation of MAKERS LABORATORIES LTD. is ₹87.33 Crores as on 24 Jul, 2026.
What are the stock symbols of MAKERS LABORATORIES LTD.?
The stock symbol of MAKERS LABORATORIES LTD. is 506919 on the BSE, and the ISIN is INE987A01010.
What was yesterday's closing price for MAKERS LABORATORIES LTD. shares ?
MAKERS LABORATORIES LTD. shares closed yesterday at ₹148.00 on BSE
How to buy MAKERS LABORATORIES LTD. shares?
To buy MAKERS LABORATORIES LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy MAKERS LABORATORIES LTD. shares on Holidays?
No, shares of MAKERS LABORATORIES LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell MAKERS LABORATORIES LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of MAKERS LABORATORIES LTD.?
The PE and PB ratio of MAKERS LABORATORIES LTD. is 33.97 and 1.09 respectively, as on 24 Jul, 2026, 15:22 IST.